Related references
Note: Only part of the references are listed.Effectiveness of elcatonin for alleviating pain and inhibiting bone resorption in patients with osteoporotic vertebral fractures
Shinya Tanaka et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2017)
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
Kenneth G. Saag et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Bio-Oss® modified by calcitonin gene-related peptide promotes osteogenesis in vitro
Yuanjing Li et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Efficacy and safety of pramlintide injection adjunct to insulin therapy in patients with type 1 diabetes mellitus: a systematic review and meta-analysis
Yong-Chao Qiao et al.
ONCOTARGET (2017)
Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy
Ashitha L. Vijayan et al.
JOURNAL OF INTENSIVE CARE (2017)
Role and mechanism of action of sclerostin in bone
Jesus Delgado-Calle et al.
BONE (2017)
Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles
Debbie L. Hay et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56 (2016)
A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D
Kim Henriksen et al.
BONE (2016)
Amylin structure-function relationships and receptor pharmacology: implications for amylin mimetic drug development
Rebekah L. Bower et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Ligand-Dependent Modulation of G Protein Conformation Alters Drug Efficacy
Sebastian George Barton Furness et al.
CELL (2016)
The expanding repertoire of receptor activity modifying protein (RAMP) function
Klara R. Klein et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2016)
Pharmacodynamics and pharmacokinetics of oral salmon calcitonin in the treatment of osteoporosis
Leonardo Bandeira et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Receptor activity-modifying protein-directed G protein signaling specificity for the calcitonin gene-related peptide family of receptors (vol 291, pg 21925, 2016)
Cathryn Weston et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Calcitonin gene-related peptide promotes the expression of osteoblastic genes and activates the WNT signal transduction pathway in bone marrow stromal stem cells
Ri Zhou et al.
MOLECULAR MEDICINE REPORTS (2016)
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
F. Cosman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Prevention of Bone Loss in a Model of Postmenopausal Osteoporosis through Adrenomedullin Inhibition
Sonia Martinez-Herrero et al.
FRONTIERS IN PHYSIOLOGY (2016)
From disease to treatment: from rare skeletal disorders to treatments for osteoporosis
Natasha M. Appelman-Dijkstra et al.
ENDOCRINE (2016)
Isolation and gene expression of haematopoietic-cell-free preparations of highly purified murine osteocytes
Ling Yeong Chia et al.
BONE (2015)
Calcitonin Gene-Related Peptide-Induced Calcium Alginate Gel Combined with Adipose-Derived Stem Cells Differentiating to Osteoblasts
Chang-zhi Huang et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2015)
A Role for the Calcitonin Receptor to Limit Bone Loss During Lactation in Female Mice by Inhibiting Osteocytic Osteolysis
Michele V. Clarke et al.
ENDOCRINOLOGY (2015)
Calcitonin Physiology, Saved by a Lysophospholipid
T. John Martin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Calcitonin gene-related peptide stimulates proliferation and osteogenic differentiation of osteoporotic rat-derived bone mesenchymal stem cells
Wei Liang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
Structural Basis for Receptor Activity-Modifying Protein-Dependent Selective Peptide Recognition by a G Protein-Coupled Receptor
Jason M. Booe et al.
MOLECULAR CELL (2015)
Effects of intermedin on proliferation, apoptosis and the expression of OPG/RANKL/M-CSF in the MC3T3-E1 osteoblast cell line
Hongfei Ren et al.
MOLECULAR MEDICINE REPORTS (2015)
Roles of receptor activity-modifying protein 1 in angiogenesis and lymphangiogenesis during skin wound healing in mice
Chie Kurashige et al.
FASEB JOURNAL (2014)
Decline in calcitonin receptor expression in osteocytes with age
Jonathan H. Gooi et al.
JOURNAL OF ENDOCRINOLOGY (2014)
Prolonged Calcitonin Receptor Signaling by Salmon, but Not Human Calcitonin, Reveals Ligand Bias
Kim Vietz Andreassen et al.
PLOS ONE (2014)
Deficiency of RAMP1 Attenuates Antigen-Induced Airway Hyperresponsiveness in Mice
Manyu Li et al.
PLOS ONE (2014)
Role of Calcitonin Gene-Related Peptide in Functional Adaptation of the Skeleton
Susannah J. Sample et al.
PLOS ONE (2014)
Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts
Johannes Keller et al.
NATURE COMMUNICATIONS (2014)
Calcitonin gene-related peptide stimulates BMP-2 expression and the differentiation of human osteoblast-like cells in vitro
Gang Tian et al.
ACTA PHARMACOLOGICA SINICA (2013)
Salmon Calcitonin Use and Associated Cancer Risk
Robert A. Overman et al.
ANNALS OF PHARMACOTHERAPY (2013)
Epidemiology and burden of osteoarthritis
Anna Litwic et al.
BRITISH MEDICAL BULLETIN (2013)
The Potential Protective Effects of Calcitonin Involved in Coordinating Chondrocyte Response, Extracellular Matrix, and Subchondral Trabecular Bone in Experimental Osteoarthritis
Tan Cheng et al.
CONNECTIVE TISSUE RESEARCH (2013)
Regulation of Adrenomedullin and its Family Peptide by RAMP System - Lessons from Genetically Engineered Mice
Takayuki Shindo et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2013)
The use of procalcitonin in the diagnosis of bone and joint infection: a systemic review and meta-analysis
C-J Shen et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2013)
Calcitonin: Physiology or fantasy?
Rachel A. Davey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Amylin exerts osteogenic actions with different efficacy depending on the diabetic status
I. Gutierrez-Rojas et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Islet amyloid polypeptide toxicity and membrane interactions
Ping Cao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Adrenomedullin22-52 Combats Inflammation and Prevents Systemic Bone Loss in Murine Collagen-Induced Arthritis
Marie-Dominique Ah Kioon et al.
ARTHRITIS AND RHEUMATISM (2012)
Synthesis and evaluation of disulfide bond mimetics of amylin-(1-8) as agents to treat osteoporosis
Renata Kowalczyk et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
How to blast osteoblasts? Novel dicarba analogues of amylin-(1-8) to treat osteoporosis
Renata Kowalczyk et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
The pharmacology of Adrenomedullin 2/Intermedin
Yanguo Hong et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Calcitonin and calcitonin receptor-like receptors: common themes with family B GPCRs?
James Barwell et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation
Hai Qing et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Mice over-expressing salmon calcitonin have strongly attenuated osteoarthritic histopathological changes after destabilization of the medial meniscus
B. C. Sondergaard et al.
OSTEOARTHRITIS AND CARTILAGE (2012)
Calcitonin substitution in calcitonin deficiency reduces particle-induced osteolysis
Max D. Kauther et al.
BMC MUSCULOSKELETAL DISORDERS (2011)
The role of the calcitonin receptor in protecting against induced hypercalcemia is mediated via its actions in osteoclasts to inhibit bone resorption
Andrew G. Turner et al.
BONE (2011)
Signal Transduction Pathways Mediating the Effect of Adrenomedullin on Osteoblast Survival
Sylvie Lausson et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Comparisons Between the Effects of Calcitonin Receptor-Stimulating Peptide and Intermedin and Other Peptides in the Calcitonin Family on Bone Resorption and Osteoclastogenesis
Susanne Granholm et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Lessons Learned From the Development of Oral Calcitonin: The First Tablet Formulation of a Protein in Phase III Clinical Trials
M. A. Karsdal et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Research Resource: Haploinsufficiency of Receptor Activity-Modifying Protein-2 (Ramp2) Causes Reduced Fertility, Hyperprolactinemia, Skeletal Abnormalities, and Endocrine Dysfunction in Mice
Mahita Kadmiel et al.
MOLECULAR ENDOCRINOLOGY (2011)
ISLET AMYLOID POLYPEPTIDE, ISLET AMYLOID, AND DIABETES MELLITUS
Per Westermark et al.
PHYSIOLOGICAL REVIEWS (2011)
Calcitonin impairs the anabolic effect of PTH in young rats and stimulates expression of sclerostin by osteocytes
J. H. Gooi et al.
BONE (2010)
Calcitonin-gene-related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-κB activation, osteoclastogenesis and bone resorption
Liping Wang et al.
BONE (2010)
Amylin(1-8) is Devoid of Anabolic Activity in Bone
Maria Ellegaard et al.
CALCIFIED TISSUE INTERNATIONAL (2010)
Neuroendocrine regulation of cyclic AMP formation in osteoblastic cell lines (UMR-106-01, ROS 17/2.8, MC3T3-E1, and Saos-2) and primary bone cells
Anders Bjurholm et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Effects of continuous calcitonin treatment on osteoclast-like cell development and calcitonin receptor expression in mouse bone marrow cultures
Mika Ikegame et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Effects of calcitonin gene-related peptide on cyclic AMP formation in chicken, rat, and mouse bone cells
V. P. Michelangeli et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Structure-activity relationships in calcitonin gene-related peptide: Cyclic AMP response in a preosteoblast cell line (ks-4)
Daniel Thiebaud et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Binding of calcitonin and calcitonin gene-related peptide to calvarial cells and renal cortical membranes
Patricia K. Seitz et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Calcitonin Gene-Related Peptide (CGRP) Inhibits Apoptosis in Human Osteoblasts by β-Catenin Stabilization
Emanuela Mrak et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Effects of alpha-calcitonin gene-related peptide on osteoprotegerin and receptor activator of nuclear factor-kappa B ligand expression in MG-63 osteoblast-like cells exposed to polyethylene particles
Jie Xu et al.
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH (2010)
Clinical significance of antibodies against calcitonin
A. Grauer et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2009)
Calcitonin receptor-stimulating peptide: Its evolutionary and functional relationship with calcitonin/calcitonin gene-related peptide based on gene structure
Takeshi Katafuchi et al.
PEPTIDES (2009)
Adrenomedullin inhibits MAPK pathway-dependent rheumatoid synovial fibroblast-mediated osteoclastogenesis by IL-1 and TNF-α
Hee-Jin Yun et al.
RHEUMATOLOGY INTERNATIONAL (2009)
The role of calcitonin and α-calcitonin gene-related peptide in bone formation
Antje K. Huebner et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2008)
The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism
D. Naot et al.
BONE (2008)
Differential responses of circulating amylin to high-fat vs. high-carbohydrate meal in healthy men
Lindsay K. Eller et al.
CLINICAL ENDOCRINOLOGY (2008)
Receptor Activity-Modifying Proteins Differentially Modulate the G Protein-Coupling Efficiency of Amylin Receptors
Maria Morfis et al.
ENDOCRINOLOGY (2008)
Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice
Rachel A. Davey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Expression of the calcitonin receptor, calcitonin receptor-like receptor, and receptor activity modifying proteins during osteoclast differentiation
Susanne Granholm et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Adrenomedullin is anti-apoptotic in osteoblasts through CGRP1 receptors and MEK-ERK pathway
Benjamin Uzan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Adrenomedullin signaling is necessary for murine lymphatic vascular development
Kimberly L. Fritz-Six et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Evidence that human cartilage and chondrocytes do not express calcitonin receptor
Z. Lin et al.
OSTEOARTHRITIS AND CARTILAGE (2008)
Salmon calcitonin: a review of current and future therapeutic indications
C. H. Chesnut et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Calcitonin inhibits osteoclast formation in mouse haematopoetic cells independently of transcriptional regulation by receptor activator of NF-κB and c-Fms
Susanne Granholm et al.
JOURNAL OF ENDOCRINOLOGY (2007)
Hypertension and dysregulated proinflarnmatory cytokine production in receptor activity-modifying protein 1-deficient mice
Kazutake Tsujikawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The effect of oral calcitonin on cartilage turnover and surface erosion in an ovariectomized rat model
Bodil-Cecilie Sondergaard et al.
ARTHRITIS AND RHEUMATISM (2007)
Receptor activity-modifying proteins 2 and 3 have distinct physiological functions from embryogenesis to old age
Ryan Dackor et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Calcitonin induces podosome disassembly and detachment of osteoclasts by modulating Pyk2 and Src activities
Jia-Fwu Shyu et al.
BONE (2007)
Calcitonin and prednisolone display antagonistic actions on bone and have synergistic effects in experimental arthritis
Lucia Mancini et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Establishment of an Osteocyte-like Cell Line, MLO-Y4
Yoichi Kato et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Calcitonin deficiency in mice progressively results in high bone turnover
Antje K. Huebner et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Calcitonin plays a critical role in regulating skeletal mineral metabolism during lactation
Janine P. Woodrow et al.
ENDOCRINOLOGY (2006)
Calcitonin directly attenuates collagen type II degradation by inhibition of matrix metalloproteinase expression and activity in articular chondrocytes
B. C. Sondergaard et al.
OSTEOARTHRITIS AND CARTILAGE (2006)
The aggregation potential of human amylin determines its cytotoxicity towards islet β-cells
Barbara Konarkowska et al.
FEBS JOURNAL (2006)
Effects of amylin deficiency on trabecular bone in young mice are sex-dependent
R. A. Davey et al.
CALCIFIED TISSUE INTERNATIONAL (2006)
GPCR modulation by RAMPS
DL Hay et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Parathyroid hormone: past and present
JT Potts
JOURNAL OF ENDOCRINOLOGY (2005)
Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging: Results from the QUEST study
CH Chesnut et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Novel function for receptor activity-modifying proteins (RAMPs) in post-endocytic receptor trafficking
JM Bomberger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes
J Roh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo
R Dacquin et al.
JOURNAL OF CELL BIOLOGY (2004)
Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator
Y Takei et al.
FEBS LETTERS (2004)
RAMPs and CRLR expressions in osteoblastic cells after dexamethasone treatment
B Uzan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Calcitonin gene-related peptide elevates calcium and polarizes membrane potential in MG-63 cells by both cAMP-independent and -dependent mechanisms
DM Burns et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2004)
Decreased bone formation and osteopenia in mice lacking α-calcitonin gene-related peptide
T Schinke et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Biological importance of the peptides of the calcitonin family as revealed by disruption and transfer of corresponding genes
R Muff et al.
PEPTIDES (2004)
Shared pathways of osteoblast mitogenesis induced by amylin, adrenomedullin, and IGF-1
J Cornish et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Is calcitonin an important physiological substance?
PF Hirsch et al.
ENDOCRINE (2003)
Calcitonin receptor-stimulating peptide, a new member of the calcitonin gene-related peptide family - Its isolation from porcine brain, structure, tissue distribution, and biological activity
T Katafuchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Human osteoblast-like cell proliferation induced by calcitonin-related peptides involves PKC activity
I Villa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene
AO Hoff et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Adrenomedullin stimulates the growth of cultured normal human osteoblasts as an autocrine/paracine regulator
H Hamada et al.
PEPTIDES (2002)
Calcitonin induces dephosphorylation of Pyk2 and phosphorylation of focal adhesion kinase in osteoclasts
Z Zhang et al.
BONE (2002)
International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors
DR Poyner et al.
PHARMACOLOGICAL REVIEWS (2002)
Forty years of calcitonin - Where are we now? A tribute to the work of Iain Macintyre, FRS
M Zaidi et al.
BONE (2002)
Multiple roles of adrenomedullin revealed by animal models
KM Caron et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2002)
Amylin and adrenomedullin: Novel regulators of bone growth
J Cornish et al.
CURRENT PHARMACEUTICAL DESIGN (2002)
Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development
J Cornish et al.
BONE (2001)
Systemic administration of adrenomedullin(27-52) increases bone volume and strength in male mice
J Cornish et al.
JOURNAL OF ENDOCRINOLOGY (2001)
Amylin and bone metabolism in streptozotocin-induced diabetic rats
MN Horcajada-Molteni et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Effects of calcitonin gene-related peptide and amylin on human osteoblast-like cells proliferation
I Villa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Systemic administration of a novel octapeptide, amylin-(1-8), increases bone volume in male mice
J Cornish et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2000)
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study
CH Chesnut et al.
AMERICAN JOURNAL OF MEDICINE (2000)
Identification of key components in the irreversibility of salmon calcitonin binding to calcitonin receptors
JM Hilton et al.
JOURNAL OF ENDOCRINOLOGY (2000)
Amylin inhibits ovariectomy-induced bone loss in rats
MN Horcajada-Molteni et al.
JOURNAL OF ENDOCRINOLOGY (2000)
Effects of CGRP on human osteoclast-like cell formation: a possible connection with the bone loss in neurological disorders?
A Akopian et al.
PEPTIDES (2000)
Share Paper
